GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Center for Glial Biology in Medicine Research Recruitment Core Center

$651,125
Harald W Sontheimer · University Of Alabama At Birmingham · P30 · FY2010 · NS

Center for Glial Biology in Medicine Research Recruitment Core Center

$651,125
Harald W Sontheimer · University Of Alabama At Birmingham · P30 · FY2009 · NS

Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis

$651,098
Monique Evangeline Hinchcliff · Yale University · R01 · FY2022 · AR

Inhibition of the Rho/MRTF/SRF Pathway as a New Treatment for Systemic Sclerosis

$651,097
Scott D Larsen · University Of Michigan At Ann Arbor · R01 · FY2015 · AR

Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD

$650,895
Jeffrey D Rothstein · Johns Hopkins University · R01 · FY2018 · NS

Interdisciplinary Immunology Training Program

$650,631
David G. Schatz · Yale University · T32 · FY2017 · AI

Myelin Content and Cognitive Trajectories in Young Adults Living with Virally Suppressed HIV

$650,472
Payal Patel · University Of Washington · R01 · FY2023 · MH

Cognitive neural prosthetics for clinical applications

$650,105
Richard A Andersen · California Institute Of Technology · R01 · FY2017 · EY

Neuronal Autophagy: a Cell-Autonomous Protection Mechanism

$650,008
Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · NS

CRCNS Research Proposal: Collaborative Research: The Space of Riemannian Metrics for the Statistical Analysis of the Human Connectome

$650,000
Sarang Joshi · University Of Utah · · FY2019 · MPS

Applying Diffusion Basis Spectrum Imaging to Characterize Human Placenta Immuno-response during normal term and preterm pregnancies

$649,905
Yong Wang · Washington University · R01 · FY2018 · HD

Development and Validation of a Self-Efficacy Item Bank

$649,834
Lisa M. Shulman · University Of Maryland Baltimore · U01 · FY2010 · AR

Metabolic predictors of disease outcomes in multiple sclerosis

$649,829
Kathryn C. Fitzgerald · Johns Hopkins University · R01 · FY2024 · NS

Improving Learning in MS: A Randomized Clinical Trial

$649,623
Nancy D. Chiaravalloti · Kessler Foundation, Inc. · R01 · FY2008 · HD

AccelBand, a leg-worn transcutaneous neuromodulation device for treating neurogenic bowel dysfunction in individuals with spinal cord injury

$649,573
Victor Pikov · Transtimulation Research, Inc. · UG3 · FY2024 · NS

Modulating glial fate and function in development and disease

$649,538
Paul Joseph Tesar · Case Western Reserve University · R35 · FY2020 · NS

How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal

$649,418
Fotini Gounari · Mayo Clinic Arizona · R01 · FY2024 · AI

How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal

$649,418
Fotini Gounari · Mayo Clinic Arizona · R01 · FY2022 · AI

How beta-catenin expands Foxp3+RORgammat+ Pro-inflammatoryT-regulatory cells - Renewal

$649,418
Fotini Gounari · Mayo Clinic Arizona · R01 · FY2023 · AI

MHC variation at high resolution in multiple sclerosis

$649,361
Jorge R. Oksenberg · University Of California, San Francisco · R01 · FY2018 · NS

It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12

$649,061
Tracy M Handel · University Of California, San Diego · R01 · FY2025 · AI

The role of mTOR signaling in oligodendrocyte differentiation and CNS myelination

$649,023
Wendy B Macklin · University Of Colorado Denver · R01 · FY2012 · NS

Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD

$648,990
Jeffrey D Rothstein · Johns Hopkins University · R01 · FY2017 · NS

CD38 modulation of NAD metabolism driving scleroderma pathogenesis

$648,599
John Varga · University Of Michigan At Ann Arbor · R01 · FY2024 · AR

Analysis and characterization of a cohort of familial Parkinson's disease exomes

$648,444
John E. Landers · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · NS